These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1482128)

  • 1. In vitro and in vivo activities of DQ-2556 and its mode of action.
    Tanaka M; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2595-601. PubMed ID: 1482128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.
    Pucci MJ; Boice-Sowek J; Kessler RE; Dougherty TJ
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2312-7. PubMed ID: 1804003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
    Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial properties of SCE-2787, a new cephem antibiotic.
    Nakao M; Noji Y; Iwahi T; Yamazaki T
    J Antimicrob Chemother; 1992 May; 29(5):509-18. PubMed ID: 1624391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime: binding affinity to penicillin-binding proteins and morphological changes of Escherichia coli and Pseudomonas aeruginosa.
    Masuyoshi S; Inoue M; Takaoka M; Mitsuhashi S
    Arzneimittelforschung; 1981; 31(7):1070-2. PubMed ID: 6268122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
    Maejima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R; Andrews JM; Cross C; Piddock LJ
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
    Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin.
    Mochizuki H; Oikawa Y; Yamada H; Kusakabe S; Shiihara T; Murakami K; Kato K; Ishiguro J; Kosuzume H
    J Antibiot (Tokyo); 1988 Mar; 41(3):377-91. PubMed ID: 3130365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
    Watanabe N; Katsu K; Moriyama M; Kitoh K
    Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
    Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
    Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Piddock LJ; Traynor EA; Griggs DJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
    Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ
    J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of cefoperazone for penicillin-binding proteins.
    Matsubara N; Minami S; Matsuhashi M; Takaoka M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):195-9. PubMed ID: 6448021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin.
    Watanabe N; Sugiyama I
    J Antibiot (Tokyo); 1992 Sep; 45(9):1526-32. PubMed ID: 1429239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus.
    Hayes MV; Orr DC
    J Antimicrob Chemother; 1983 Aug; 12(2):119-26. PubMed ID: 6413485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative affinities for penicillin-binding proteins of multipolar ionic amphoteric cephalosporins in gram-negative bacteria.
    Fontana R; Valisena S; Cornaglia G
    J Chemother; 1996 Feb; 8 Suppl 2():23-30. PubMed ID: 8738843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.